Using mobile technology to support lower-salt food choices for people with cardiovascular disease: protocol for the SaltSwitch randomized controlled trial

BackgroundCardiovascular disease (CVD) is the leading cause of early death worldwide, responsible for an estimated 29% of all global deaths. Reducing salt intake lowers blood pressure and risk of secondary cardiac events. However, identifying low salt foods can be challenging. SaltSwitch is a simple smartphone application (app) that enables shoppers to scan the barcode of packaged foods and receive an immediate, interpretive, traffic light nutrition label on the screen, along with suggestions for healthier lower-salt alternatives. A growing body of evidence suggests mobile technologies can support healthy behaviour change. However, robust evidence for the impact of smartphone interventions is lacking. This manuscript outlines the rationale and methods for a randomized controlled trial designed to determine the effectiveness of SaltSwitch in supporting people with CVD to make lower-salt food choices.Design/MethodsA 6-week, two-arm, parallel, randomized controlled trial is being undertaken in New Zealand (2 weeks baseline and 4 weeks intervention). Three hundred adults aged 40 years and older with CVD and their main household shoppers are recruited from research lists, cardiac rehabilitation clinics, and communities in Auckland. Participants are randomized to receive either the SaltSwitch smartphone app or no intervention (control). Randomisation is stratified by ethnicity and age. The primary outcome is the salt content of household food purchases. Secondary outcomes are the saturated fat and energy content of household food purchases, household food expenditure, use and acceptability of the SaltSwitch app by shoppers, and urinary sodium and blood pressure of participants with CVD. Ambulatory blood pressure and potential longer-term impact (12 weeks) of SaltSwitch will be assessed in sub-studies (n ~ 40 and n ~ 20, respectively). Household purchases of salt and other nutrients will be assessed using till receipt data electronically linked with branded food composition data.DiscussionThe results of the SaltSwitch trial will determine the effectiveness, use and acceptability of a smartphone application to support lower salt food choices and secondary prevention of CVD.Trial registrationACTRN12614000206628. Registered 30 March 2014.

[1]  D. Istance Organization for Economic Co-operation and Development , 1966, Nature.

[2]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[3]  M. Tobias,et al.  Explaining trends in coronary heart disease hospitalisations in New Zealand: trend for admissions and incidence can be in opposite directions , 2008, Heart.

[4]  Alan D. Lopez,et al.  The Global Burden of Disease Study , 2003 .

[5]  Sandra Capra,et al.  Nutrient reference values for Australia and New Zealand: Including recommended dietary intakes , 2006 .

[6]  Shah Ebrahim,et al.  Promoting patient uptake and adherence in cardiac rehabilitation. , 2014, The Cochrane database of systematic reviews.

[7]  M. Nelson,et al.  Comparison between household budget survey and 24-hour recall data in a nationally representative sample of Polish households , 2005, Public Health Nutrition.

[8]  J. Mckenney,et al.  Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.

[9]  Vera Bittner,et al.  Referral, enrollment, and delivery of cardiac rehabilitation/secondary prevention programs at clinical centers and beyond: a presidential advisory from the American Heart Association. , 2011, Circulation.

[10]  R. McLean,et al.  Monitoring population sodium intake using spot urine samples: validation in a New Zealand population , 2014, Journal of Human Hypertension.

[11]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[12]  J. Stone,et al.  Canadian guidelines for cardiac rehabilitation and atherosclerotic heart disease prevention: a summary. , 2001, The Canadian journal of cardiology.

[13]  R. Lappalainen,et al.  Why cardiac patients do not follow the nutritionist's advice: barriers in nutritional advice perceived in rehabilitation. , 1996, Disability and rehabilitation.

[14]  D. Panagiotakos,et al.  Can a Mediterranean diet moderate the development and clinical progression of coronary heart disease? A systematic review. , 2004, Medical science monitor : international medical journal of experimental and clinical research.

[15]  A. Bell,et al.  Internet trends in New Zealand, 2007-2013 , 2014 .

[16]  G. Bray,et al.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. , 2001, The New England journal of medicine.

[17]  Tony Blakely,et al.  Effects of price discounts and tailored nutrition education on supermarket purchases: a randomized controlled trial. , 2010, The American journal of clinical nutrition.

[18]  Ian J. Brown,et al.  Salt intakes around the world: implications for public health. , 2009, International journal of epidemiology.

[19]  D. Moher,et al.  SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) , 2014 .

[20]  W. Parnell,et al.  Providing additional money to food-insecure households and its effect on food expenditure: a randomized controlled trial , 2012, Public Health Nutrition.

[21]  Shah Ebrahim,et al.  Promoting patient uptake and adherence in cardiac rehabilitation. , 2014, The Cochrane database of systematic reviews.

[22]  Orton,et al.  EFFECTS ON BLOOD PRESSURE OF REDUCED DIETARY SODIUM AND THE DIETARY APPROACHES TO STOP HYPERTENSION ( DASH ) DIET , 2000 .

[23]  L. Swartz,et al.  Scaling Up mHealth: Where Is the Evidence? , 2013, PLoS medicine.